Study of PAL-222 for stubborn skin ulcers
Part of Skin clinical trials.
This trial tests a new treatment, PAL-222, for skin ulcers that haven't improved much after 4 weeks of standard care. It aims to see if PAL-222 can help these wounds heal better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 20 years or older.
- Your skin ulcer has shrunk less than 50% after at least 4 weeks of standard treatment.
- After cleaning the wound, the ulcer is between 1 and 3 square centimeters.
- The ulcer is within 5 centimeters of the area to be treated.
- There are no signs of infection in the ulcer.
- If bone is exposed, it covers less than 10% of the ulcer area.
- If the ulcer is on your lower leg or foot, your skin's blood flow (measured as skin reflux pressure) is at least 30 mmHg.
- You can understand the trial information and give written consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares several advanced wound treatments (called CAMPs) plus standard care versus standard care alone for diabetic foot ulcers that are slow to heal. The goal is to see if adding these treatments helps ulcers close faster.
This study tests two new skin graft products (PelloGraft for diabetic foot ulcers and SanoGraft for venous leg ulcers) to see if they heal wounds faster than standard care. If you have a hard-to-heal foot or leg ulcer, this trial may offer a new option.
This trial tests whether adding a special treatment (cellular acellular and matrix-like products) to standard wound care helps diabetic foot ulcers and venous leg ulcers heal faster. It may be an option if you have a diabetes-related foot ulcer that hasn't healed with standard care.
This trial tests different wound-healing products (called CAMPs) to see if they work better than standard care for hard-to-heal pressure ulcers (bedsores). It might be a good fit if you have a long-lasting stage 3 or 4 bedsore on your trunk that is not infected.
This study tests whether a treatment made from your own blood (platelet-rich plasma or platelet-rich fibrin) can help heal chronic skin ulcers better than standard care. If you have a non-healing ulcer that fits the size and duration criteria, and you are generally healthy, you may be able to participate.
This early-phase study tests whether lab-made stem cells from donated umbilical cord tissue are safe for treating a skin ulcer. It mainly looks at side effects and whether the treatment can be given safely.
Hear when a new Refractory Skin Ulcer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.